{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:42:08Z","timestamp":1789011728923,"version":"build-2803163510"},"reference-count":27,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.3960\/jslrt.22011","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T22:11:05Z","timestamp":1656367865000},"page":"79-84","source":"Crossref","is-referenced-by-count":24,"title":["Idiopathic plasmacytic lymphadenopathy: A conceptual history along with a translation of the original Japanese article published in 1980"],"prefix":"10.3960","volume":"62","author":[{"given":"Kengo","family":"Takeuchi","sequence":"first","affiliation":[{"name":"Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan,"},{"name":"Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Wu D, Lim MS, Jaffe ES. Pathology of Castleman Disease. Hematol Oncol Clin North Am. 2018; 32: 37-52.","DOI":"10.1016\/j.hoc.2017.09.004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972; 29: 670-683.","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#"},{"key":"3","unstructured":"3 Flendrig J. Benign giant lymphoma: Clinicopathologic correlation study. In: Clark R, Gumley R (eds): The Year Book of Cancer. Chicago, Year Book Medical Publishers. 1970; pp. 296-299."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Case 40011. N Engl J Med. 1954; 250: 26-30.","DOI":"10.1056\/NEJM195401072500107"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer. 1956; 9: 822-830.","DOI":"10.1002\/1097-0142(195607\/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Facchetti F, Simbeni M, Lorenzi L. Follicular dendritic cell sarcoma. Pathologica. 2021; 113: 316-329.","DOI":"10.32074\/1591-951X-331"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Zhou T, Wang HW, Pittaluga S, Jaffe ES. Multicentric Castleman disease and the evolution of the concept. Pathologica. 2021; 113: 339-353.","DOI":"10.32074\/1591-951X-351"},{"key":"8","unstructured":"8 Mori S, Mohri N. [Clinicopathological analysis of systemic nodal plasmacytosis with severe polyclonal hyperimmunoglobulinemia]. Proceedings of the Japanese Society of Pathology. 1978; 67: 252-253."},{"key":"9","unstructured":"9 Mori S, Mohri N, Uchida T, Shimamine T. [Idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia: a syndrome related to giant lymph node hyperplasia of plasma cell type]. The Journal of the Japanese Society for Lymphoreticular Tissue Research. 1980; 20(suppl): 55-65."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Frizzera G, Banks PM, Massarelli G, Rosai J. A systemic lymphoproliferative disorder with morphologic features of Castleman\u2019s disease. Pathological findings in 15 patients. Am J Surg Pathol. 1983; 7: 211-231.","DOI":"10.1097\/00000478-198304000-00001"},{"key":"11","unstructured":"11 Frizzera G. Castleman\u2019s disease and related disorders. Semin Diagn Pathol. 1988; 5: 346-364."},{"key":"12","unstructured":"12 Mori S. [IPL (idiopathic plasmacytic lymphadenopathy)]. CURRENT THERAPY. 1991; 9: 53-54."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman\u2019s disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol. 1985; 3: 1202-1216.","DOI":"10.1200\/JCO.1985.3.9.1202"},{"key":"14","unstructured":"14 Frizzerra G. Atypical lymphoproliferative disorders. In: Knowles DM (ed): Neoplastic Hematopathology. 2 ed, Philadelphia, Lippincott Williams & Wilkins. 2001; pp. 569-622."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Soulier J, Grollet L, Oksenhendler E et al.<\/i> Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u2019s disease. Blood. 1995; 86: 1276-1280.","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Katano H, Sato Y, Kurata T, Mori S, Sata T. High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi\u2019s sarcoma. Am J Pathol. 1999; 155: 47-52.","DOI":"10.1016\/S0002-9440(10)65097-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Suda T, Katano H, Delsol G et al.<\/i> HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman\u2019s disease. Pathol Int. 2001; 51: 671-679.","DOI":"10.1046\/j.1440-1827.2001.01266.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Kojima M, Nakamura S, Shimizu K et al.<\/i> Clinical implication of idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobulinemia: a report of 16 cases. Int J Surg Pathol. 2004; 12: 25-30.","DOI":"10.1177\/106689690401200104"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Bouzani M, Apostolidis J, Rondogianni D et al.<\/i> Idiopathic plasmacytic lymphadenopathy with polyclonal gammopathy in a patient of Western origin. Int J Surg Pathol. 2005; 13: 125-126.","DOI":"10.1177\/106689690501300121"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Kojima M, Nakamura N, Tsukamoto N et al.<\/i> Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases. Int J Surg Pathol. 2008; 16: 391-398.","DOI":"10.1177\/1066896908315812"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kawabata H, Takai K, Kojima M et al.<\/i> Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly: a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012). J Clin Exp Hematop. 2013; 53: 57-61.","DOI":"10.3960\/jslrt.53.57"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014; 123: 2924-2933.","DOI":"10.1182\/blood-2013-12-545087"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kojima M, Nakamura N, Tsukamoto N et al.<\/i> Multicentric Castleman\u2019s disease representing effusion at initial clinical presentation: clinicopathological study of seven cases. Lupus. 2011; 20: 44-50.","DOI":"10.1177\/0961203310381510"},{"key":"24","unstructured":"24 Takai K, Nikkuni K, Shibuya H, Hashidate H. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki. 2010; 51: 320-325."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Wang HW, Pittaluga S, Jaffe ES. Multicentric Castleman disease: where are we now? Semin Diagn Pathol. 2016; 33: 294-306.","DOI":"10.1053\/j.semdp.2016.05.006"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Fajgenbaum DC, Uldrick TS, Bagg A et al.<\/i> International, evidence-based consensus diagnostic criteria for HHV-8\u2013negative\/idiopathic multicentric Castleman disease. Blood. 2017; 129: 1646-1657.","DOI":"10.1182\/blood-2016-10-746933"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Nishimura MF, Nishimura Y, Nishikori A, Yoshino T, Sato Y. Historical and pathological overview of Castleman disease. J Clin Exp Hematop. 2022; [Onlin ahead of print].","DOI":"10.3960\/jslrt.21036"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/2\/62_22011\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:43:02Z","timestamp":1715233382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/62\/2\/62_22011\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.22011","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"22011"}}